Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Acta Neuropathologica|February 22, 2019
Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigmsMaria Masnata, Giacomo Sciacca, Alexander Maxan, et al.
Neural Regeneration Research|May 31, 2024
Additive neurorestorative effects of exercise and docosahexaenoic acid intake in a mouse model of Parkinson's diseaseOlivier Kerdiles, Méryl-Farelle Oye Mintsa Mi-Mba, Katherine Coulombe, et al.
Cellular and Molecular Life Sciences : CMLS|January 18, 2023
Detection of antibodies against the huntingtin protein in human plasmaHélèna L Denis, Melanie Alpaugh, Claudia P Alvarez, et al.
Scientific Reports|August 4, 2016
microRNA-132/212 deficiency enhances Aβ production and senile plaque deposition in Alzheimer's disease triple transgenic miceJulia Hernandez-Rapp, Sara Rainone, Claudia Goupil, et al.
Parkinsonism & Related Disorders|September 18, 2021
Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experienceAurelie de Rus Jacquet, Sarah Bogard, Catherine P Normandeau, et al.
Cells|November 27, 2021
DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal RhabdomyosarcomaSimona Camero, Giulia Vitali, Paola Pontecorvi, et al.
Neurobiology of Disease|October 10, 2024
Treatment with Tau fibrils impact Huntington's disease-related phenotypes in cell and mouse modelsShireen Salem, Melanie Alpaugh, Martine Saint-Pierre, et al.
Brain Research|January 15, 2019
The toxin MPTP generates similar cognitive and locomotor deficits in hTau and tau knock-out miceMaud Gratuze, Nicolas Josset, Franck R Petry, et al.
Annals of Neurology|May 7, 2014
Mutant huntingtin is present in neuronal grafts in Huntington disease patientsFrancesca Cicchetti, Steve Lacroix, Giulia Cisbani, et al.
Pageof 9